JUSTINE BARNAO: Open Payments
NPI 1861916702 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 38 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $794 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $150 |
| SCPHARMACEUTICALS INC. | 3 | $129 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Actelion Pharmaceuticals US, Inc. | 6 | $101 |
| Imperative Care, Inc | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
Products named: AMVUTTRA, FUROSCIX, LEQVIO, UPTRAVI, LifeVest, VERQUVO, REPATHA, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
